AI-generated analysis. Always verify with the original filing.
Inovio Pharmaceuticals, Inc. furnished Item 2.02 results of operations and Exhibit 99.1 Press Release dated March 12, 2026, via Form 8-K filed on 2026-03-12. The disclosure is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
Event Type
Disclosure
Mandatory
Variant
8-K
and Exhibit 99.1 hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “
Financial Statements and Exhibits. (d) Exhibits Exhibit Number 99.1 Press Release, dated March 1 2 , 202 6 (filed herewith) 104 Cover Page Interactive Data File